American University of Beirut Medical Center
Home / Publications Faculty of Medicine

Calcium Metabolism & Osteoporosis Program 		AUB

Home
About Us
Services
Medical Conditions
BMD Guidelines
OSTEOS
Quality Assurance
Education
Research
Publications
News
Resources
Sitemap
Contact Us
Publications
  1. Rolla AR, El-Hajj Fuleihan GA,Goldstein H. Untreated thyrotoxicosis as a manifestation of anorexia nervosa.  Am J Med 1986; 81:163-5.
  2. Warren HB, Lausen GGN, Segre GV, El-Hajj Fuleihan GA,Brown EM. Regulation of calcitropic hormones in vivo in the New Zealand white rabbit. Endocrinology 1989;125:268-90.
  3. El-Hajj Fuleihan GA, Chen CJ, Rivkees SA, Marynick SP, Stock J Pallotta JA, Brown EM. Calcium dependent release of intact parathyroid hormone by human pathologic parathyroid tissue in vitro. J Clin Endocrinol Metab 1989; 69: 860-7
  4. El-Hajj Fuleihan GA, Brown EM. Effect of the lectin Con A on calcium regulated cAMP accumulation in bovine parathyroid cells. Endocrinology 1990; 126: 1996-2002
  5. Brown EM, El-Hajj Fuleihan GA, Chen CJ, Kifor O. A comparison of the effects of divalent and trivalent cations on PTH release, cAMP accumulation, and the levels of inositol phosphates in bovine parathyroid cells. Endocrinology 1990; 127:1064-71.
  6. LeBoff MS, Wade JP, Mackowiack S, El-Hajj Fuleihan G, Zangari Liang H. Low dose prednisone does not affect calcium homeostasis or bone density in post menopausal women with rheumatoid arthritis. J Rheumatology 1991; 18: 339-44
  7. El-Hajj Fuleihan GA, Katz G, Kifor O, Gleason R, Brown EM. Effects of the lectin concanavalin-A on the regulation of second messengers and PTH release in bovine parathyroid cells. Endocrinology 1991; 128: 2931-36.
  8. LeBoff MS,El-Hajj Fuleihan G, Angell JE, Chung S, Curtis K. Dual x-ray absorptiometry of the forearm: reproducibility and correlation with single photon absorptiometry. J Bone Miner Res 1992; 7: 841-46
  9. Brown EM, Butters R, Katz C, Kifor O, El-Hajj Fuleihan G. A comparison of the effects of concanavalin A and TPA on the modulation of parathyroid function by extra cellular calcium and neomycin in dispersed bovine parathyroid cells. Endocrinology 1992; 130: 3143-3151
  10. Jacobus CH, Holick MF, Qing S,Chen TC, Holm I, Kolodny J, El-Hajj Fuleihan G, Seely EW. Hypervitaminosis associated with drinking milk. New Engl J Med 1992; 326: 1174-76.
  11. Chou YH, Brown EM, Levi T, Growe G, Atkinson AB, Arquist IJ, Toss G El-Hajj Fuleihan G, Seidman JG, Seidman CE. The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3 in four unrelated families. Nat Genet 1992; 1: 295-300.
  12. El-Hajj Fuleihan G, Brown EM, Curtis K, Berger M, Berger B, Gleason R, LeBoff MS. Effect of sequential and daily continuous hormone replacement therapy on indices of mineral metabolism. Arch Int Med 1992; 152: 1904-1909.
  13. Rivkees SA, El-Hajj Fuleihan G, Brown EM, Crawford JD. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab 1992; 75: 1514-1518.
  14. El-Hajj Fuleihan G, Gundberg CM, Gleason R, Brown EM, Stomski ME Grant FD, Conlin PR. Racial differences in parathyroid hormone dynamics. J Clin Endocrinol Metab 1994; 79: 1642-1647
  15. El-Hajj Fuleihan G, Testa MA, Angell JE, Porrino N, LeBoff MS Reproducibility of DXA absorptiometry: A model for bone loss estimates. J Bone Miner Res 1995; 10: 1004-1014.
  16. Paz-Pacheco E, El-Hajj Fuleihan G, Testa MA, Angell JE, Porrino N, LeBoff. Reproducibility of DXA absorptiometry: A model for bone loss estimates.J Bone Miner Res 1995; 10:1004-1014.
  17. El-Hajj Fuleihan G, Brown EM, Gleason R, Scott J, Adler GK. Calcium modulation of adrenocorticotropic hormone levels in women. J Clin Endocrinol Metab 1996; 81: 932-936.
  18. El-Hajj Fuleihan G, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA. The parathyroid hormone circadian rhythm is truly endogenous. J Clin Endocrinol Metab 1997; 82: 281-286 (PDF).
  19. El-Hajj Fuleihan G, Tissue-specific estrogens—the promise for the future. EditorialN Engl J Med 1997; 337:1686-1687 (PDF).
  20. Carroll J, Testa MA, Erat K, LeBoff MS, El-Hajj Fuleihan G. Modeling fracture risk using bone density age, and years since menopause. Am J Preventive Med 1997; 13:447-452.
  21. Haden ST, Stoll AL, McCormick S, Scott J, El-Hajj Fuleihan G. Alterations in parathyroid dynamics in lithium-treated subjects. J Clin Endocrinol Metab 1997; 82: 2844-48 (PDF).
  22. El-Hajj Fuleihan G, Seifter J, Scott J, Brown EM. Calcium regulated renal calcium handling in healthy men: relationship to sodium handling. J Clin Endocrinol Metab 1998;83:2366-2372 (PDF).
  23. El-Hajj Fuleihan G. Osteoporosis: an Update. Lebanese Medical Journal 1998; 46: 23-28 (PDF).
  24. McClung M, Clemmesen B, Daifotis A, Gilchrist NL, Eisman J Weinstein RS, El-Hajj Fuleihan G, Reda C, Yates AJ, Ravn P, for the Alendronate Osteoporosis Prevention Study Group . Alendronate prevents postmenopausal osteoporosis. Ann Int Med 1998; 128:253-261.
  25. El-Hajj Fuleihan G. Moore F, Testa M, LeBoff M, Angell J, Scott J Longitudinal changes in bone density in hyperparathyroidism. J Clin Densitometry 1999; 2(2):153-162 (PDF).
  26. Haden ST, Stoll AL, McCormick S, Scott J, El-Hajj Fuleihan G. The effect of lithium on calcium-induced changes in adrenocorticotrophin levels. J Clin Endocrinol Metab 1999;84:198-202 (PDF).
  27. Haden ST, El-Hajj Fuleihan G, Angell JE, Cotran NM, LeBoff MS, Calcidiol and PTH levels in women attending an Osteoporosis Program. Calcified Tissue Int 1999; 64: 275-79 (PDF).
  28. Porter L, Conlin P, Scott J, Brown EM, El-Hajj Fuleihan G. Calcium modulation of the renin aldosterone axis. J Endocrinol Investigation 1999; 22: 115-21.
  29. El-Hajj Fuleihan G, Deeb M. Letter to the Editor. Hypovitaminosis in a Sunny Country. N- Engl J Med 1999; 340: 1840-41 (PDF).
  30. El-Hajj Fuleihan G. Osteoporosis : an overview of practice guidelines or BMD measurements and osteoporosis treatment strategies. Lebanese Med Liban Journal 1999; 47: 222-228 (PDF).
  31. Haden S, Stoll A, McCormick S, Scott J, El-Hajj Fuleihan G. Effects of age and gender on PTH dynamics. Clinical Endocrinology 2000; 52: 329-338 (PDF).
  32. El-Ali Hussam, El-Hajj Fuleihan G. Nutritional Osteomalacia: Substantial Clinical Improvement and Gain in Bone density Post-Therapy. J Clin Densit 2000; 3: 97-101(PDF)
  33. Ravn P, Weiss SR, Rodriguez-Portales JA, McClung MR, Wasnich RD, Gilchrist NL, Sambrook P, Fogelman I, Krupa D, Yates JA, Daifotis A, El-Hajj Fuleihan G. Alendronate in early postmenopausal women: effects on bone mass during long term treatment and after withdrawal. J Clin Endocrinol Metab 2000; 85: 1492-97 (PDF).
  34. El-Hajj Fuleihan G. Hormone Replacement Therapy. Ed A. Wayne Meikle. N Eng J Med 2000; 342: 297-298. Book Review (PDF).
  35. El-Hajj Fuleihan G, Nabulsi M, Shoucair M, Salamoun M, Hajj-Shahine C, Kizirian A,Tannous R. Hypovitaminosis D in Healthy School Children. Pediatrics 2001; 107: 1-7 (PDF).
  36. Arabi A, Roux C. Les Rhumatologues et la DHEA. La letter du rhumatologue, 276: 20-25; 2001.
  37. El- Hajj Fuleihan G, Stock J, Saifi G, McClung M. Bone density reporting in the United States: a national survey. J Clin Densitom 2002; 5:1-7(PDF).
  38. Younis H, Farhat G,El-Hajj Fuleihan G. Efficacy and tolerability of cyclical intravenous pamidronate in patients with low bone mass. J Clin Densitom 2002;5(2):1-7(PDF).
  39. El-Ali H, Abu Yabis A, Issa E, Salem Z, Tawil A, Khoury N, El-Hajj Fuleihan G. Hypercalcemia in Langerhan cell granulomatosis with elevated calcitriol levels. Bone 2002; 30:331-334 (PDF).
  40. Farhat G, Yamout B, Mikati MA,Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002; 58: 1348-1353 (PDF).
  41. El-Hajj Fuleihan G, Baddoura R, Awada H, Salam N, Salamoun M, Rizk P. Low peak bone mineral density in healthy Lebanese subjects. Bone 2002; 31: 520-8 (PDF).
  42. El-Hajj Fuleihan G. Familial benign hypocalciuric hypercalcemia. J Bone Miner Res 2002; 87: 353-5361
  43. Bilezikian JP, Potts JT, El-Hajj Fuleihan G, Kleerekpor M, Neer R, Rastad J, Silverberg SJ, Udelsman R, Wells SA. Summary statement from a workshop on asymptomatic hyperparathyroidism: a perspective for the 21 century. J Bone Miner Res 2002; N2-N11.
  44. Bilezikian JP, Potts JT, El-Hajj Fuleihan G, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA. Summary statement from a workshop on asymptomatic hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002;87:353-5361 (PDF).
  45. El-Hajj Fuleihan G, Baddoura R, Awada H, Rizk P, McClung M. Lebanese guidelines for osteoporosis assessment and treatment. Lebanese Medical Journal 2002; 50:76-125 (PDF).
  46. Eid-Fares J, Shoucair M, Nabulsi M, Salamoun M, Hajj-Shahine M, El-Hajj Fuleihan G . Effect of gender, puberty, and vitamin D status on biochemical markers of bone remodeling. Bone 2003; 33: 242-247 (PDF).
  47. Roux C, Arabi A, Porcher R, Garnero P. Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone 33:847-52; 2003.
  48. Arabi A, Garnero P, Porcher P, Pelissier C, Benhamou C, Roux C. Body composition changes during hormone replacement therapy: A two-year prospective study. Hum Reprod 18:1747-52; 2003.
  49. Asma Arabi, Patrick Garnero, Raphaël Porcher, Clara Pelissier, Claude Laurent Benhamou, Christian Roux. Body composition changes during hormone replacement therapy: A two-year prospective study. Hum Reprod 18:1747-52; 2003.
  50. Christian Roux, Asma Arabi, Raphaël Porcher, Patrick Garnero. Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone 33:847-52; 2003.
  51. Zayour D, Daouk M, Salamoun M, Medawar W, El-Hajj Fuleihan G. Bone mineral metabolism and density in patients on dialysis. Transplant Proc 2004; 36:1297-1301 (PDF).
  52. El-Hajj Fuleihan G. Strontium ranelate: a novel therapy for osteoporosis or a permutation of the same? Editorial. N Engl J Med 2004; 350: 504-506 (PDF) .
  53. Lewiecki M, Kendler, Kiebzak G, Schmeer P, El-Hajj Fuleihan G , Prince R, Hans D. Special report on the official positions of the International Society for Clinical Densitometry. Osteoporos Int 2004; 15:779-784 (PDF).
  54. Kendler D, David Kendler, M.D., Annie Wai Chee Kung, MBBS, MD, FHKCP, FHKAM (Med), FRCP, El-Hajj Fuleihan G, M.D., M.P.H., José Gerardo, González González, M.D., Keavy A. Gaines, Nadia Verbruggen, M. Sc., Mary E. Melton, M.D. Patients with osteoporosis prefer once weekly to daily dosing with alendronate. Maturitas 2004";48:243-251 (PDF).
  55. Arabi A, Nabulsi M, Maalouf J, Shoucair M, Khalife H, Vieth R, El-Hajj Fuleihan G. Bone mineral density by age, gender, pubertal stages and socioeconomic status in healthy Lebanese children and adolescents. Bone 2004; 35:1169-1179 (PDF).
  56. Boonen S, McClung M, Eastell R, El-Hajj Fuleihan G, Barton I, Delmas P. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women 80 years of age and older: Implications for the use of antiresorptive drugs in the old and the oldest old. J Am Geriatr Soc 2004, 52: 1832-1839 (PDF)
  57. Hreybeh H, Salamoun M, Badra M, Afeiche N, Baddoura O, Boulos S, Haidar R, Lakkis R, Musharafieh R, Nsouli A, Taha A, Tayim A, El-Hajj Fuleihan G. Hip fractures in Lebanese patients: determinants and prognosis. J Clin Densitom 2004;7:368-375 (PDF).
  58. Arabi A, Tamim H, Nabulsi M, Maalouf J, Khalife H, Shoucair M, Veith R, El-Hajj Fuleihan G. Sex differences in the effect of body-composition variables on bone mass in healthy children and adolescents Am J Clin Nutr 2004; 80:1428-1435 (PDF) .
  59. Salamoun M, Kiizirian A, Tannous R, Deeb M, El-Hajj Fuleihan G. Low calcium and vitamin D intake in healthy adolescents and their correlates. Eur J Clin Nutr 2005;59:177-184 (PDF).
  60. Veith R, El-Hajj Fuleihan G. There is no lower threshold for parathyroid hormone as 25 –hydroxy vitamin D concentration increases. J Endocrinol Invest 2005:28:183-186 (PDF).
  61. El-Hajj Fuleihan G, Baddoura R, Awada H, McClung M. Lebanese Guidelines for osteoporosis assessment and treatment. J Clinical Densitom 2005; 8:148-163 (PDF).
  62. Dib L, Arabi A, Nabulsi M, Maalouf J, El-Hajj Fuleihan G. Impact of anthropometric, lifestyle and body composition variables on ultrasound measurements in healthy children. Bone 2005; 36:736-742 (PDF).
  63. Arabi A, Salamoun M, Ballout H, El-Hajj Fuleihan G. Impact of densitometer on risk assessment for osteoporosis. J Clin Densitometry 2005; 8:261-266 (PDF).
  64. Abou Samra R, Hwalla Baba N, Torbay N, Dib L, El-Hajj Fuleihan G. High plasma leptin level is not associated with higher bone mineral density in hyperinsulinemic premenopausal women. J Clin Endocrinol Metab 2005;90:2588-2594 ( PDF).
  65. El-Hajj Fuleihan G, Salamoun M, Abou Mourad Y, Chehal A, Salem Z, Mahfoud Z, Shamseddine A. Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial. J Clin Endocrinol Metab 2005;90:3209-3214 (PDF).
  66. Arabi A. Leptin effect on bone: is it ethnic specific? [Editorial]. J Lab Clin Med 146:7-8; 2005 (PDF).
  67. Forin V, Arabi A, Guigonis V, Filipe G, Bensman A,Roux C. Benefits of pamidronate in children with Osteogenesis Imperfecta: A prospective study. Joint Bone Spine 72:313-318; 2005(PDF).
  68. El-Hajj Fuleihan G, Nabulsi M, Tamim, Maalouf J, Salamoun M, Khalifeh, Shoucair M, Arabi A, Vieth R. Effect of vitamin D replacement on musculoskeletal parameters in healthy school children: a randomized controlled trial. J Clin Endocrinol Metab 2006;91:405-412 (PDF).
  69. Arabi A, Baddoura R, Awada H, Salamoun M, Ayoub G, El-Hajj Fuleihan G. Hypovitaminosis D osteopathy: Is it mediated through PTH, lean mass, or is it a direct effect? Bone 2006;39:268-275 (PDF).
  70. Baddoura R, Awada H, Okais J, Salamoun M, Ayoub G, Ziade N, El-Hajj Fuleihan G. An audit of densitometry practice in reference to IOF, NOF and ISCD guidelines. Osteoporos Int. 2006;17(7):1111-5 (PDF).
  71. Arabi A, Khoury N, Birbari A, Zahed L, El-Hajj Fuleihan G. Regression of skeletal manifestations of hyperparathyroidism with oral vitamin D. J Clin Endocrinol Metab. 2006;91(7):2480-3(PDF).
  72. Mikati M, Dib L, Sawaya R, Yamout B, El-Hajj Fuleihan G. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone. Neurology 2006(11):2005-2014 (PDF).
  73. Véronique Forin, Asma Arabi, Vincent Guigonis, Georges Filipe, Albert Bensman, Christian Roux. Benefits of pamidronate in children with Osteogenesis Imperfecta: A prospective study. Joint Bone Spine 72:313-318; 2005.
  74. Asma Arabi, Leptin effect on bone: is it ethnic specific? [Editorial]. J Lab Clin Med 146:7-8; 2005.
  75. William D. Leslie, Robert A. Adler, El-Hajj Fuleihan G, Anthony Hodsman, David L. Kendler, Michael McClung, Paul Miller, Nelson Watts. Application of the 1994 WHO Classification to Populations Other Than Postmenopausal Caucasian Women: The 2006 ISCD Official Positions. J Clinic Densitom 2006;9(1):22-30 (PDF).
  76. Arabi A, Baddoura R, Awada H, Khoury N, Hadda-zebouni S, Ayoub G,and El-Hajj Fuleihan G. Discriminative ability of dual-energy x-ray ‎absorptiometry site selection in identifying patients with osteoporotic ‎fractures. Bone 2007; Apr;40(4):1060-5 (PDF).
  77. Baddoura R, Arabi A, Haddad-Zebouni S, Khoury N, Salamoun M, Ayoub G, Awada H, and El-Hajj Fuleihan G. Vertebral fracture risk and impact; of database selection on identifying elderly with osteoporosis. Bone 2007; Apr;40(4):1066-72 (PDF).
  78. Khairallah W, Fawwaz A, Brown EM, El-Hajj Fuleihan G. Hypercalcemia and diabetes; insipidus in a patient previously treated with lithium for 20 years. Nature. Clinical Practice Nephrology 2007;3(7): 397-404 (PDF).
  79. Asma Arabi, Dany Zayour, Ibrahim Salti. Papillary carcinoma arising in a thyroglossal duct cyst 2 Case reports and review of the literature. International Surgery, 92 (6): 327-330; 2007.
  80. Arabi A, Zayour D,Salti I. Papillary carcinoma arising in a thyroglossal duct cyst 2 Case reports and review of the literature. International Surgery, 92 (6):327-330;2007.
  81. Nabulsi M, Mahfoud Z, Maalouf J, Arabi A, El-Hajj Fuleihan G. Impact of maternal ‎veiling during pregnancy and socioeconomic status on offspring’s musculoskeletal health. Osteoporos Int 2008;(PDF) .
  82. Gordon CM, Bachrach LK, Carpenter TO, Crabtree N, El-Hajj Fuleihan G, Kutilec S, Lorenc RS, Tosi LL, Ward KA, Ward LM, Kalkwarf HJ. J Clin Densitom 2008; 11(1): 43-58.
  83. El-Hajj Fuleihan G, Dib L, Yamout B, Sawaya R, Mikati M. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone 2008, (PDF)
  84. Maalouf J, Nabulsi M, Vieth R, Kimball S, El-Rassi R, Mahfoud Z and El-Hajj Fuleihan G. Short term and long term safety of vitamin D 3 supplementation in school children. J Clin Endocrinol Metab 2008; (PDF).
  85. El-Hajj Fuleihan G, Badddoura R, Awada H, Arabi A, Okais J. First Update of Lebanese Guidelines for Osteoporosis Assessment and Treatment. J Clin Densitom 2008; (PDF) .
  86. El-Hajj Fuleihan G.Tibolone and the Promise of Ideal Hormone Replacement therapy. New England J Med 2008;359(7): 753-755. (PDF)
  87. El-Hajj Fuleihan G. Editorial. Hyperparathyroidism: time to reconsider current clinical decision paradigms? J Clin Endocrinol Metab 2008; 93(9): 3302- 3304; (PDF)
  88. Arabi Asma, El-Hajj Fuleihan G. How effective is risedronate in preventing bone loss in patients on high dose steroids? Invited Practice Point Commentary. Nature Clinical Practice Endocrinology 2008; 4(10):540-541(PDF).
Reviews in Books or Journals:
  1. Brown EM, Chen CJ, LeBoff MS, Kifor O, Oetting MH .  El-Hajj Fuleihan G. Mechanisms underlying the inverse control of parathyroid hormone secretion by calcium In: Secretion and its Control . Rockfeller University Press, 1989:251-68.

  2. Brown EM, Chen CJ, Kifor O, LeBoff MS, El-Hajj Fuleihan G, Fajtova V, Rubin LT. Ca++ -sensing, second messengers, and the control of parathyroid hormone secretion. In: Cell Calcium 1990;11:333-337.

  3. El-Hajj Fuleihan G, Brown EM. Familial benign hypocalciuric hypercalcemia and neonatal hyperparathyroidism. Clinical Reviews in Bone Mineral Metabolism 2002; 1:77-84.
  4. Kovacs Christopher, El-Hajj Fuleihan G. Calcium and bone disorders during pregnancy. In Pregnancy and endocrine disorders. Endocrine Clinics of North America 2006; 35:21-51 (PDF).
  5. Rubeiz N, El-Hajj Fuleihan G. Dermatologic manifestations of parathyroid related disorders. In: Endocrinology in dermatology. Clinics in Dermatology 2006; 2006;24(4):281-288 (PDF).
  6. El-Hajj Fuleihan G, Vieth R. Vitamin D insufficiency and musculoskeletal ‎health in children and adolescents. International Congress Series, Elsevier,2007;1297:91-108 (PDF).
  7. Kimball S, El-Hajj Fuleihan G, Vieth R. Vitamin D: A Growing Perspective. Critical Reviews in Clinical Laboratory Sciences 2008; 45(4): 339-415 (PDF) .
Books and Monographs:
  1. LeBoff MS, El-Hajj Fuleihan G, Brown EM. Osteoporosis and Paget’s Disease of Bone. In: Branch Jr WT ed. Office Practice of Medicine. Musculoskeletal Disorders. Philadelphia: WB Saunders, 1994:700-714.

  2. Diaz R, El-Hajj Fuleihan G, Brown EM. Parathyroid and polyhormones. Handbook of Physiology. Chapter 12.

  3. El-Hajj Fuleihan G, Heath Hunter III. Familial Benign hypocalciuric hypercalcemia. In: “The Parathyroids : Basic and Clinical Concepts “. Eds Bilezikian JP, Marcus R, Levine MA. Academic Press 2001 San Diego, CA.

  4. El-Hajj Fuleihan G, Brown EM, Heath H III. The Familial Benign Hypocalciuric Hypercalcemic Syndromes. In: “Principles of Bone Biology” Eds Bilezikian JP, Raisz LG, Rodan GA. Academic Press 2007, San Diego, CA.
  5. Juppner H, El-Hajj Fuleihan G. Measurement of Parathyroid Hormone. In : “ Dynamics of Bone and Cartilage Metabolism: Principles and Clinical Applications”. Second Edition. Eds Markus J. Seibel, Simon P. Robins and John P. Bilezekian. Elsevier Inc. 2006.

Non-Print Material Up-To Date CD-ROM: Up-To Date in Endocrinology and Metabolism CD-ROM
  1. El-Hajj Fuleihan G. Diagnosis and differential diagnosis of primary hyperparathyroidism.

  2. El-Hajj Fuleihan G. Clinical manifestations of primary hyperparathyroidism.

  3. El-Hajj Fuleihan G. Pathogenesis and etiology of primary hyperparathyroidism.

  4. El-Hajj Fuleihan G. Parathyroid carcinoma and parathyroid cysts.

  5. Agus Z, El-Hajj Fuleihan G. Preoperative localization in hyperparathyroidism.

  6. Agus Z, El-Hajj Fuleihan G. Management of primary hyperparathyroidism
  7. El-Hajj Fuleihan G. Parathyroid hormone secretion and action

  8. El-Hajj Fuleihan G Patient Information. Primary Hyperparathyroidism
  9. Jüppner H and El-Hajj Fuleihan G. New parathyroid hormone assays and their clinical use.

Abstracts:
  1. Fajtova VT, El-Hajj Fuleihan G, Lazarus MJ, Williams WW, Brown EM, LeBoff MS. Validation and application of an intact parathyroid hormone assay in dialysis patients. J Bone Mineral Res 1989; 4(suppl 1):Abstract 75.

  2. El-Hajj Fuleihan G, Brown EM, Curtis K, Gleason R, LeBoff MS. Cyclical versus daily continuous hormonal therapy for osteoporosis. J Bone Miner Res. 5(supppl 2):Abstract 438,1990.

  3. El-Hajj Fuleihan G, Kifor O, Katz C, Brown EM. Effects of con A on the regulation of second messengers and PTH release by Ca 2+ in bovine parathyroid cells. J Bone Miner Res 5(Suppl 2): Abstract 457, 1990.

  4. Brown EM, El-Hajj Fuleihan G, Kifor O, Chen C. Comparative effects of di- and trivalent cations on cAMP, inositol phosphates and PTH release in bovine parathyroid cells. American Society of Bone and Mineral Research. August, 1990.
  5. Gibbons WE, Judd HL, Luciano AA, Natchingall LE, Dawood MY, Burry K, Ziel H, LeBoff MS, El-Hajj Fuleihan G, Orgine F, Schoenfield MJ, Buvalos RP, Adashi E, Schantz P. Comparison of sequential versus continuous estrogen/progestin replacement therapy on serum lipid patterns. Multiuniversity National Upjohn Study Collaborative. Society for Gynecologic Investigation, March 1991.

  6. Gibbons WE, Judd HL, Moyer D, Natchingall LE, Burry K, Luciano AA, Dawood MY, Zeil H, Schantz P, Buvalos RP, Orgine F, Schoenfeld MJ, El-Hajj Fuleihan G, LeBoff MS, Adashi E. Evaluation of sequential versus estrogen/progestin replacement therapy on uterine bleeding patterns and endometrial histology. Multiuniversity National Upjohn Study Collaborative. Society for Gynecologic Investigation, March 1991.

  7. McClung MR, El-Hajj Fuleihan G, LeBoff MS, Luciano AA, Gibbons WE, Burry K, Ogrinc FG, Schoenfeld MJ. Comparison of sequential versus continuous estrogen/progesterone replacement therapy on bone density. J Bone Miner Res 1991; 6(Suppl 1):Abstract 783.

  8. Paz-Pacheco E, El-Hajj Fuleihan G, LeBoff MS. Intact PTH levels are not elevated in steroid-treated osteoporotics. J Bone Miner Res 1991; 6(Suppl 1):Abstract 373.

  9. El-Hajj Fuleihan G, Porrino N, Angell J, Chung S, LeBoff MS. The reproducibility of bone density analysis dual x-ray absorptiometry. American Society of Bone and Mineral Research Minneapolis 1992:Abstract 391.

  10. El-Hajj Fuleihan G, Gundberg C, Porrino N, Brown EM. Parathyroid hormone dynamics in black subjects. J Bone Miner Res 1992;7(Suppl 2):Abstract 580.

  11. El-Hajj Fuleihan G, Porrino N, Brown E, Czeiler C. Parathyroid hormone diurnal rhythm is truly endogenous. J Bone Miner Res 1993;8(Suppl1):Abstract 284.

  12. El-Hajj Fuleihan G, Hall J, Porrino N, Gleason R, Crowly B. Intact parathyroid hormone level across the menstrual cycle. J Bone Miner Res 1993;8(Suppl 1):Abstract 285.

  13. El-Hajj Fuleihan G, Moore F, LeBoff M, Porrino N, Angell J, Brown E, Weinreb J. Serial changes in bone mineral density and hyperparathyroidism. J Bone Miner Res 1993; 8(Suppl 1):Abstract 452.

  14. El-Hajj Fuleihan G, Testa M, Angell J, Porrino N, LeBoff M. Precision of dual energy x-ray absorptiometry a model for bone loss estimate. J Bone Miner Res 1993; 8(Suppl 1):Abstract 913.

  15. El-Hajj Fuleihan G, Gleason R, Scott J, Angell J, Dingley N, LeBoff MS. Upgrading of dual energy scanners. J Bone Miner Res 1994; 8 (Suppl 1):Abstract.

  16. El-Hajj Fuleihan G, Scott J, Brown EM, Gleason R, Adler G. Effects of Ca on ACTH release. Endocrine Society Meeting 1995.

  17. Carroll J, Testa MA, Erat K, LeBoff MS, El-Hajj Fuleihan G. Fracture risk assessment model using DXA. The Endocrine Society 1995.

  18. Porter L, Conlin P, Scott J, Brown EM, El-Hajj Fuleihan G. Calcium regulation of the renin-angiotensin system. Annual Meeting of the Endocrine Society 1996, San Francisco.

  19. Haden ST, Kohlmeier LA, El-Hajj Fuleihan G, Cotran N, Angell JE, LeBoff MS. Secondary causes of bone loss: presence of low vitamin D levels. J Bone Miner Res 1996; 11(Suppl 1):Abstract T540.

  20. El-Hajj Fuleihan G, Moore F, Jr, Gleason R, LeBoff M, Angell J, Scott J. Combined estrogen therapy and surgery in hyperparathyroidism. J Bone Miner Res 1996; 11(Suppl 1):Abstract T607.

  21. El-Hajj Fuleihan G, Scott J, Brown EM. Extra cellular Ca regulated Ca handling. Oral Presentation J Bone Miner Res 1996;11(Suppl 1): Abstract 104.

  22. El-Hajj Fuleihan G, Klerman B, Brown E, Czeiler CA. N-Tx diurnal rhythm is truly endogenous. J Bone Miner Res 1997; 12 (Suppl 1) Abstract S613.

  23. El-Hajj Fuleihan G, Orav J. Intersite differences in bone mass: A parathyroid hormone related event ? J Bone Miner Res 1997; 12 (Suppl 1):Abstract F434.

  24. El-Hajj Fuleihan G, Luckey M, Bauer R, Wasnick R, Krupa D, Reda C, Yates AJ, Daifotis A, for the Alendronate Protocol 029 Study Group. Effects of discontinuation of alendronate in early postmenopausal women. Oral Presentation J Bone Miner Res 1997; 12 (Suppl 1) Abstract 164.

  25. Haden ST, Scott J, El-Hajj Fuleihan G. Age and gender effects on PTH dynamics. J Bone Miner Res 1997; 12 (Suppl 1) : Abstract F384.

  26. Haden ST, Cristiano LM, El-Hajj Fuleihan G. Bone loss and risk factors pre and post lung transplantation. J Bone Miner Res 1997; 12 (Suppl 1) Abstract F698.

  27. Haden ST, Stoll AL, McCormick S, Scott J, El-Hajj Fuleihan G. The effect of lithium on calcium-induced changes in adrenocorticotrophin levels. J Bone Miner Res 1997; 12 (Suppl 1) Abstract S407 .

  28. El-Hajj Fuleihan G, Stock JL, Saifi G, McClung MR. Bone mineral density reporting in the US: a national random survey. J Bone and Miner Res 1999; 14(Suppl 1) Abstract:F219.

  29. El-Hajj Fuleihan G, Nabulsi M, Shoucair M, Rouhana AN, Shahine CH. Prevalence of vitamin D insufficiency in school children in Beirut. (Project 1) J Bone Miner Res 1999; 14 (Suppl 1) Abstract SA456.

  30. El-Hajj Fuleihan G, Nabulsi M, Shoucair M, Rouhana AN, Shahine CH. Prevalence of vitamin D insufficiency in school children in Beirut. (Project 2) First Pan Arab Congress of Endocrinology and Metabolism. October 2000, Bristol, Beirut, Lebanon.

  31. El-Hajj Fuleihan G, Nabulsi M, Shoucair M, Salamoun M, Shahine CH. Hypovitaminosis D in Healthy School Children. (Project 3) J Bone Miner Res 2000; 15 (Suppl 1) Abstract M494.

  32. El-Hajj Fuleihan G, Baddoura R, Awada H, Salam N, Salamoun M, Rizk P. Bone Mineral Density and its Predictors in Healthy Young Lebanese Subjects: a Multicenter Study. J Bone Miner Res 2000; 15 (Suppl 1) Abstract SU287.

  33. Arabi A, Salti I. Thyroglossal Duct Cyst Carcinoma: Case report and review of the literature. Presented by Asma Arabi at the 2nd Pan Arab Congress of Endocrinology 2000-Amman-Jordan.
  34. El-Hajj Fuleihan G, Badra M, Tayim A, Makari M, Salamoun M, Afeiche N, Baddoura O, Boulos S, Haidar R, Lakkis S, Musharrafieh R, Nsouli A, Taha A. Lebanese patients with hip fractures are relatively young, but have osteoporosis. J Bone Miner Res 2001; Suppl 1: Abstract M 337.

  35. Eid-Fares J, Shoucair M, Nabulsi M, Salamoun M, Hajj-Shahine M, El-Hajj Fuleihan G. Effect of gender, puberty, and vitamin D status on biochemical markers of bone remodeling. Second International Conference on Children’s Bone Health, Sheffield, Calcified Tissue International 2002; 70 (5): Abstract 28, p 369.

  36. El-Hajj Fuleihan G, Zayour D, Daouk M, Medawar W, Salamoun M. Predictors of bone mineral density in dialysis. J Bone Mineral Res 2002 Supl (1): Abstract M 337.

  37. El-Hajj Fuleihan G, Badra M, Tayim A, Salamoun M, Afeiche N, Baddoura O, Boulos R, Haidar R, Lakkis S, Musharrafieh R, Nsouli A, Taha A, Makari G. Total body fat as a predictor of hip fracture. J Bone Mineral Res 2002 Supl (1): Abstract 1393.

  38. Forin V, Arabi A,Filipe G,Bensman A, Roux C. Benefits of pamidronate in children with osteogenesis imperfecta: 8th International Conference on Osteogenesis Imperfecta 2002: Annecy-France.
  39. Arabi A, Roux C, Porcher R, Benhamou C, Garnero P. Leptin and body composition changes during hormone replacement therapy: 24th annual meeting of the American Society for Bone and Mineral Research (ASBMR) 2002: San Antonio-Texas-USA.
  40. Arabi A, Shoucair M, Nabulsi M, Maalouf J, Dib L, Veith R, El-Hajj Fuleihan G. Lean mass as a major determinant of bone mass in puberty. 5th International Symposium on Nutritional Aspects of Osteoporosis, Lausanne, Switzerland, May 14-17, 2003.

  41. Arabi A, Nabulsi M, Shoucair M, Dib L, Maalouf J, Vieth R, El-Hajj Fuleihan G. Lean mass as a major determinant of bone mass in puberty. 5th International Symposium on Nutritional Aspects of Osteoporosis, Lausanne, Switzerland, May 14-17, 2003.

  42. Hreybe H, Salamoun M, Badra M, Affeich N, Baddoura O, Boulos S, Haidar R, Lakkis S, Musharrafieh R, Nsouli A, Taha A, Tayim A, El-Hajj Fuleihan G. Hip Fractures in Lebanese Patients: Determinants and Prognosis. ASBMR September 2003.

  43. Maalouf J, Zahed L, Vieth R, Nabulsi M, Shoucair M, El-Hajj Fuleihan G. VDR Polymorphysims and Musculoskeletal parameters in Lebanese adolescents. ASBMR September 2003.
  44. Salamoun M, Shamseddine A, Chehal A, Abou Mourad Y, Salem Z, Arslanian Y, El-Hajj Fuleihan G. Pamidronate in the prevention of chemotherapy induced bone loss in premenopausal women with breast cancer. ASBMR September 2003.

  45. Arabi A, Shoucair M, Nabulsi M, Maalouf J, Vieth R, El-Hajj Fuleihan G. Bone mineral density by age, gender and pubertal stages in healthy Lebanese children and adolescents. J Bone Miner Res 2003; vol 18( supll 2): Abstract SU 008
  46. Dib L, Salamoun M, Kizirian A, Maalouf J, Tannous R, Nabulsi M, Shoucair M, Arabi A, Deeb M, Veith R, El-Hajj Fuleihan G. Lifestyle factors, vitamin D and bone health in Lebanese school students: a call for action. UNESCO, December 2003.
  47. Mikati.M, Dib. L, Yamout. B, Sawaya. R, El-Hajj Fuleihan G. Effect of Long Term Antiepileptic Therapy on Bone Density and Response to Different Doses of Vitamin D: Two Randomized Trials in Children and Adults. ASBMR October 2004.

  48. El-Hajj Fuleihan G, Nabulsi. M, Tamim. H, Maalouf. J, Salamoun. M, Shoucair. M, Viet.R. Impact of Vitamin D supplementation on musculoskeletal parameters in adolescents: a randomized trial. ASBMR October 2004.

  49. Dib. L, Abou Samra. R, Hwalla. N, Torbay. N, El-Hajj Fuleihan G . The Fat Endocrine Axis And Bone Metabolism In Obese Premenopausal Women. ASBMR October 2004.

  50. Arabi. A, Baddoura. R, Awada. H, Salamoun. M, El-Hajj Fuleihan G. Hypovitaminosis D in a sunny country and its relation to musculoskeletal health in the elderly. ASBMR October 2004.

  51. Maalouf J, Mahfouz Z, Arabi A, Nabulsi M, El-Hajj Fuleihan G. Calciotropic hormones, mineral and bone metabolism across puberty. Third International conference on Children's Bone Health , Sorrento Italy May 11-14, 2005.
  52. Farah C, El-Hajj Fuleihan G. Hypovitaminosis D in the pediatric population in a tertiary referral center in Lebanon. Third International conference on Children's Bone Health, Sorrento, Italy, May 11-14, 2005.
  53. Farah C,El-Hajj Fuleihan G. Hypovitaminosis D in the pediatric population in a tertiary referral center in Lebanon. Third International conference on Bone Health in Children, Sorrento, Italy, May 11-14 2005-Bone 2005; vol 36( suppl 1): PF 20.
  54. Dib L, Mikati MA, Yamout B, Sawaya R, El-Hajj Fuleihan G. Predictors Of Bone Mineral Density In Patients On Antiepileptic Drugs. 27th Annual Meeting of the American Society of Bone and Mineral Research , September 23-27, 2005, Nashville, Tennessee, USA.
  55. Arabi A, Awada H, Baddoura R, Haddad S, Khoury NJ, Ayoub G, El-Hajj Fuleihan G. Fracture risk assessment model: do values derived from Western populations apply to other Caucasians? 27th Annual Meeting of the American Society of Bone and Mineral Research , September 23-27, 2005, Nashville, Tennessee, USA.
  56. Arabi A, Baddoura R, Awada H, Khoury NJ, Haddad S, Ayoub G, El-Hajj Fuleihan G. Fracture risk assessment using a local versus an international reference database. 27th Annual Meeting of the American Society of Bone and Mineral Research , September 23-27, 2005, Nashville, Tennessee, USA.
  57. Kimball SM, El-Hajj Fuleihan G, Vieth R. Dosing with the upper limit for vitamin D3 intake has no effect on serum calcium or calcitriol levels in school children. 13th on Vitamin D, Victoria, British Columbia, Vancouver, April 8-12, 2006.
  58. Nabulsi M., Mahfoud Z., Maalouf J., Arabi A., El-Hajj Fuleihan G. Effect of maternal veiling on adolescent musculoskeletal health. 6th International Symposium on Nutritional Aspects of Osteoporosis Lausanne-Switzerland May 2006
  59. Jomaa L., Maalouf J., Dib L., El-Hajj Fuleihan G. Reproducibility and validity of a food frequency questionnaire for rapid assessment of dietary calcium intake and activity level in Lebanese children and adolescents. 6th International Symposium on Nutritional Aspects of Osteoporosis Lausanne-Switzerland May 2006.
  60. Jomaa L., Muwakkit S., Chaiban J.,Abboud M., El-Hajj Fuleihan G. Calcium intake and vitamin D levels in ALL Lebanese Children. 6th International Symposium on Nutritional Aspects of Osteoporosis Lausanne-Switzerland May 2006.
  61. Arabi A, Bazerbachi A, Dib L, Makaram J, Hatoum H, Kanj Abdel Rahman, El-Hajj Fuleihan G. Prevention of post-bone marrow transplantation bone loss with Zoledronate. What is New in Bisphosphonates? Eighth workshop on Bisphosphonates, Davos, March 22-25, 2006, Switzerland.

  62. Jomaa L., Maalouf J.,Dib L.,El-Hajj Fuleihan G. Reproducibility and validity of a food frequency questionnaire for rapid assessment of dietary calcium intake and activity level in Lebanese children and adolescents. 6th International Symposium on Nutritional Aspects of Osteoporosis Lausanne-Switzerland May 2006.

  63. Jomaa L., Muwakkit S., Chaiban J.,Abboud M.,El-Hajj Fuleihan G. Calcium intake and vitamin D levels in ALL Lebanese Children. 6th International Symposium on Nutritional Aspects of Osteoporosis Lausanne-Switzerland May 2006.

  64.  Chaiban. J,  Muwakkit. S, Jomaa. L , Abboud. M, El-Hajj Fuleihan G. Pathophysiology of metabolic bone disease in children with malignancies.  28th Annual Meeting of the American Society of Bone and Mineral Research, Sept14-19, Philadelphia, Pennsylvania.

  65. Maalouf J, Hwalla N, Mahfoud Z, Obeid O, El-Hajj Fuleihan G. Sexual Dimorphism in the Relationship ‎between Serum Leptin and Skeletal Health in Healthy Adolescents. 29th Annual Meeting of the ‎American Society for Bone and Mineral Research, 16-19 September 2007, Hawaii, Honolulu.‎

  66. Al Mukaddam M, Albany C, Hajj-Shahine C, El-Hajj Fuleihan G. Comparison of Rapid Intraoperative ‎Parathyroid Hormone to IRMA in Patients with Hyperparathyroidism. 29th Annual Meeting of the ‎American Society for Bone and Mineral Research, 16-19 September 2007, Hawaii, Honolulu.‎

  67. Arabi A, Mahfoud Z, Zahed L, Maalouf J, Nabusli M, Choucair M, El-Hajj Fuleihan G. Vitamin D ‎Receptor Gene Polymorphisms modulate the Musculoskeletal Response to Vitamin D Supplementation ‎in Healthy Girls. 29th Annual Meeting of the American Society for Bone and Mineral Research, 16-19 ‎September 2007, Hawaii, Honolulu.‎

  68. Arabi A, Zahed L, Mahfoud Z, Maalouf J, Nabusli M, Choucair M, El-Hajj Fuleihan G. Lack of Major ‎Survival Benefit of Vitamin D Receptor Gene Polymorphisms. 29th Annual Meeting of the American ‎Society for Bone and Mineral Research, 16-19 September 2007, Hawaii, Honolulu.‎
Calcium Metabolism & Osteoporosis Program American University of Beirut Medical Center Department of Internal Medicine